Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 37, Issue 3

Issues

Apheresis of Plasma Compounds as a Therapeutic Principle in Severe Sepsis and Multiorgan Dysfunction Syndrome

Bernd Stegmayr
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.1999.055

Abstract

During sepsis there is an increase in the plasma content of several compounds, e.g., bacterial toxins, cytokines, cell debris, free hemoglobin and myoglobin. In blood, these compounds activate various cascade systems, which in large amounts or in more vulnerable patients lead to a disseminated intra-vascular coagulopathy (DIC) with multiorgan dysfunction syndrome (MODS) and death, despite conventional intensive care unit therapy. Therapeutic attempts to reverse these conditions have so far been of limited benefit. These effects have mainly been focused on lowering the blood concentration of single substances such as tumor necrosis factor.

By the use of low-and high-flux hemodialysis filters, usually only small amounts of these substances are removed. By the use of plasmapheresis or plasma exchange, the extent of removal is considerably increased. The efficacy varies between the techniques (centrifugation vs. filtration or adsorption) and has also different influences on e.g. the complement system. This report describes these techniques and the therapeutical possibilities given by them. In small trials, blood or plasma exchange has been used as rescue therapy in critically ill patients with a progressive MODS and DIC. A survival of about 80 % of the patients has been reported in these studies and the use of combined therapy will be discussed. Controlled trials are required in this field.

About the article

Published Online: 2005-06-01

Published in Print: 1999-03-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 37, Issue 3, Pages 327–332, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.1999.055.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Shinsaku Imashuku, Kikuko Kuriyama, Tomoko Teramura, Eiichi Ishii, Naoko Kinugawa, Masahiko Kato, Masahiro Sako, and Shigeyoshi Hibi
Journal of Clinical Oncology, 2001, Volume 19, Number 10, Page 2665
[2]
Trung C. Nguyen and Yong Y. Han
Organogenesis, 2011, Volume 7, Number 1, Page 28
[3]
Michael J. Mosier, Phillip J. DeChristopher, and Richard L. Gamelli
Journal of Burn Care & Research, 2013, Volume 34, Number 3, Page 289
[5]
Esteban Poch, Elisabeth D. Riviello, and Kenneth Christopher
Medicina Clínica, 2008, Volume 130, Number 4, Page 141
[7]
John A. Kellum
Critical Care Medicine, 2003, Volume 31, Number 1, Page 323
[8]
Norbert Lameire and Raymond Vanholder
Current Opinion in Anaesthesiology, 2000, Volume 13, Number 2, Page 105
[9]
Shinsaku Imashuku, Yasuhiro Tabata, Tomoko Teramura, and Shigeyoshi Hibi
Leukemia & Lymphoma, 2000, Volume 39, Number 1-2, Page 37
[10]
Nele Van de Noortgate, Francis Verbeke, Annemieke Dhondt, Francis Colardijn, Wim Van Biesen, Raymond Vanholder, and Norbert Lameire
Seminars in Dialysis, 2008, Volume 15, Number 2, Page 127
[11]
Giorgio Berlot, Umberto Lucangelo, and Giovanni Galimberti
Current Opinion in Critical Care, 2000, Volume 6, Number 6, Page 437
[12]
Ericka Fink, Barbara W. Brandom, and Klaus D. Torp
Pediatric Emergency Care, 2006, Volume 22, Number 7, Page 510
[13]
Claudia Haltern, Michael Kirschfink, Rolf Rossaint, and Juliane K. Unger
Artificial Organs, 2005, Volume 29, Number 4, Page 306
[15]
Diabetic Medicine, 2000, Volume 17, Number 1, Page 2
[16]
Andy Hodgson, Tom Ryan, Jan Moriarty, George Mellotte, Ciaran Murphy, and Owen P. Smith
British Journal of Haematology, 2002, Volume 116, Number 4, Page 905

Comments (0)

Please log in or register to comment.
Log in